Kristiansen, I S <br/><br/>
Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.  [electronic resource] 

 -  Arthritis and rheumatism  Nov 1999 
 - 2293-302 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0004-3591 
<br/><br/><label>Standard No.: </label>10.1002/1529-0131(199911)42:11<2293::AID-ANR6>3.0.CO;2-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Inflammatory Agents, Non-Steroidal--adverse effects<br/>Anti-Ulcer Agents--adverse effects<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Cost-Benefit Analysis<br/>Diclofenac--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Gastric Mucosa--drug effects<br/>Health Status<br/>Humans<br/>Misoprostol--adverse effects